Molecular Docking and Dynamics Simulation Studies Predict Potential Anti-ADAR2 Inhibitors: Implications for the Treatment of Cancer, Neurological, Immunological and Infectious Dise...

por Broni, Emmanuel, Striegel, Andrew, Ashley, Carolyn, Sakyi, Patrick O., Peracha, Saqib, Velazquez, Miriam, Bebla, Kristeen, Sodhi, Monsheel, Kwofie, Samuel K., Ademokunwa, Adesanya, Khan, Sufia, Miller, Whelton A.
Publicado 2023

In Silico Discovery of Potential Inhibitors Targeting the RNA Binding Loop of ADAR2 and 5-HT2CR from Traditional Chinese Natural Compounds

por Broni, Emmanuel, Ashley, Carolyn, Velazquez, Miriam, Khan, Sufia, Striegel, Andrew, Sakyi, Patrick O., Peracha, Saqib, Bebla, Kristeen, Sodhi, Monsheel, Kwofie, Samuel K., Ademokunwa, Adesanya, Miller, Whelton A.
Publicado 2023

T098: Brentuximab Vedotin plus ESHAP (BRESHAP) versus ESHAP in Patients with Relapsed or Refractory Classical Hodgkin’s Lymphoma. Interim Results of the BRESELIBET Prospective Clin...

por Sureda-Balari, Anna, Terol, M. José, Domingo-Domènech, Eva, Rodriguez, Ana Pilar González, Mohedo, Francisca Hernández, Céspedes, Javier Núñez, De La Cruz Vicente, Fátima, Muñoz, Carmen Martínez, Díaz, M. Elena Amutio, Córdoba, Raul, Izquierdo, Antonia Rodríguez, Domínguez, Samuel Romero, Meijide, Javier Briones, Greil, Richard, Velázquez, Miriam Moreno, Rubio, Araceli, Oteiro, Mariana Bastos, Gómez, Pilar, Avivi, Irit, Casanova, María, Del Campo García, Raquel, Noriega, Victor, Blanco, José Javier Sánchez, Sanz, Ramón. García
Publicado 2022